1. WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015.
http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf
. Accessed 28 Mar 2017.
2. WHO. Emergence and spread of artemisinin resistance calls for intensified efforts to withdraw oral artemisinin monotherapy from the market. Geneva: World Health Organization; 2014.
http://www.who.int/malaria/publications/atoz/oral-artemisinin-based-monotherapies-1may2014.pdf
. Accessed 28 Mar 2017.
3. World Health Assembly Mandate 60.18, 2007.
http://apps.who.int/gb/ebwha/pdf_files/WHASSA_WHA60-Rec1/E/cover-intro-60-en.pdf
. Accessed 28 Mar 2017.
4. WHO. Marketing of oral artemisinin-based monotherapy medicines. Positions expressed by manufacturers. Geneva: World Health Organization; 2015.
http://www.who.int/malaria/monotherapy_manufacturers.pdf?ua=1
. Accessed 28 March 2017.
5. O’Connell KA, Poyer S, Solomon T, Munroe E, Patouillard E, Njogu J. Methods for implementing a medicine outlet survey: lessons from the anti-malarial market. Malar J. 2013;12:52.